Cargando…

Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators

BACKGROUND: Novel coronavirus disease 2019 (COVID-19) is frequently compared with influenza. The Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) conducts studies on the etiology and characteristics of U.S. hospitalized adults with influenza. It began enrolling patients with COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talbot, H Keipp, Martin, Emily T, Gaglani, Manjusha, Middleton, Donald B, Ghamande, Shekhar, Silveira, Fernanda P, Murthy, Kempapura, Zimmerman, Richard K, Trabue, Christopher H, Olson, Samantha M, Petrie, Joshua G, Ferdinands, Jill M, Patel, Manish M, Monto, Arnold S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195096/ https://www.ncbi.nlm.nih.gov/pubmed/34050659 http://dx.doi.org/10.1093/cid/ciab123

Ejemplares similares

Relevance of RSV in hospitalized adults and the need for continued testing
por: Miller, Katherine, et al.
Publicado: (2022)

995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016
por: Alyanak, Elif, et al.
Publicado: (2018)

150. Relative Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017
por: Doyle, Joshua, et al.
Publicado: (2018)

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018
por: Silveira, Fernanda P, et al.
Publicado: (2019)

Predictors of Clinical Respiratory Virus Testing Among Adults Hospitalized with Acute Respiratory Illness (ARI) (2015–2016)
por: Strickland, Courtney, et al.
Publicado: (2017)

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017
por: Gaglani, Manjusha, et al.
Publicado: (2020)

Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
por: Jackson, Michael L., et al.
Publicado: (2021)

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018
por: Kim, Sara S, et al.
Publicado: (2019)

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
por: McLean, Huong Q., et al.
Publicado: (2015)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
por: Havers, Fiona P., et al.
Publicado: (2018)

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial
por: Gaglani, Manjusha, et al.
Publicado: (2022)

Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020
por: Naleway, Allison L, et al.
Publicado: (2023)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022)

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016
por: Havers, Fiona P, et al.
Publicado: (2017)

Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16
por: Appiah, Grace D., et al.
Publicado: (2018)

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018
por: Flannery, Brendan L, et al.
Publicado: (2018)

2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018
por: Smith, Emily, et al.
Publicado: (2019)

Frequency of Acute Respiratory Illnesses and Circulation of Respiratory Viruses in Households With Children Over 3 Surveillance Seasons
por: Monto, Arnold S., et al.
Publicado: (2014)

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness
por: Flannery, Brendan, et al.
Publicado: (2020)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2023)

Performance of Self-Collected Anterior Nasal Swabs and Saliva Specimens for Detection of SARS-CoV-2 During Symptomatic and Asymptomatic Periods
por: Grijalva, Carlos G, et al.
Publicado: (2021)

Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
por: Petrie, Joshua G., et al.
Publicado: (2016)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2021)

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
por: Flannery, Brendan, et al.
Publicado: (2018)

Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
por: Flannery, Brendan, et al.
Publicado: (2017)

Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
por: Tartof, Sara Y., et al.
Publicado: (2023)

Influenza Vaccination and Treatment with Antiviral Agents Among Hospitalized Adults in the 2014–2015 and 2015–2016 Influenza Seasons
por: E Segaloff, Hannah, et al.
Publicado: (2017)

Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and Demographics
por: Li, Jonathan Z., et al.
Publicado: (2014)

Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?
por: Malosh, Ryan E, et al.
Publicado: (2021)

Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibodies After 2010–2011 Trivalent Inactivated Influenza Vaccination in Healthcare Personnel
por: Laguio-Vila, Maryrose R., et al.
Publicado: (2014)

Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan
por: Monto, Arnold S, et al.
Publicado: (2020)

Estimated Hospitalization Rates for Seasonal Influenza in Adults and Children in Middle Tennessee using a Capture-Recapture Method
por: Ivey, Kelsey S, et al.
Publicado: (2017)

Determination of Eligibility for Influenza Research: A Clinical Informatics Approach
por: Silveira, Fernanda P, et al.
Publicado: (2019)

Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022
por: Ahmed, Faruque, et al.
Publicado: (2023)

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018
por: Ladva, Chandresh N, et al.
Publicado: (2019)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2022)

K‐medoids clustering of hospital admission characteristics to classify severity of influenza virus infection
por: Leis, Aleda M., et al.
Publicado: (2023)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease
por: Benoit, Anne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pnu3p6uh44depvt8lb5f9ibv53